COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,387 Articles (22,816 medRxiv, 8,571 bioRxiv)

Most recent first Previous |  Page 2317: Articles 23161-23170  | Next

Data-driven Optimized Control of the COVID-19 Epidemics
Shirin, A., Lin, Y. T., Sorrentino, F.
10.1101/2020.08.27.20183574 — Posted: 2020-09-01
Seroprevalence of SARS-CoV-2 in slums and non-slums of Mumbai, India, during June 29-July 19, 2020
Malani, A., Shah, D., Kang, G., Lobo, G. N., Shastri, J., Mohanan, M., Jain, R., Agrawal, S. T., Juneja, S., Imad, S., Kolthur-Seetharam, U.
10.1101/2020.08.27.20182741 — Posted: 2020-09-01 Discussion: Offsite
Seroprevalence of SARS-CoV-2 in Palestine: a cross-sectional seroepidemiological study
Qutob, N., Awartani, F., Salah, Z., Asia, M., Abu Khader, I., Herzallah, K., Balqis, N., Sallam, H.
10.1101/2020.08.28.20180083 — Posted: 2020-09-01
A Systematic Review of Droplet and Aerosol Generation in Dentistry
Innes, N., Johnson, I., Al-Yaseen, W., Harris, R., Jones, R., KC, S., McGregor, S., Robertson, M., Wade, W., Gallagher, J.
10.1101/2020.08.28.20183475 — Posted: 2020-09-01
Practical challenges to the clinical implementation of saliva for SARS-CoV-2 detection
Matic, N., Stefanovic, A., Leung, V., Lawson, T., Ritchie, G., Li, L., Champagne, S., Romney, M. G., Lowe, C. F.
10.1101/2020.08.27.20170589 — Posted: 2020-09-01
Assessment of the Publication Trends of COVID-19 Systematic Reviews and Randomized Controlled Trials
Taito, S., Kataoka, Y., Ariie, T., Oide, S., Tsujimoto, Y.
10.1101/2020.08.27.20182956 — Posted: 2020-09-01
Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study
LOMBARDI, A., Duiella, S., Li Piani, L., Ceriotti, F., Oggioni, M., Muscatello, A., Bandera, A., Gori, A., Ferrazzi, E.
10.1101/2020.08.27.20183624 — Posted: 2020-09-01
Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China
Yang, J., Chen, X., Deng, X., Chen, Z., Gong, H., Yan, H., Wu, Q., Shi, H., Lai, S., Ajelli, M., Viboud, C., Yu, H.
10.1101/2020.08.27.20183228 — Posted: 2020-09-01
Analysis and validation of a highly sensitive one-step nested quantitative real-time polymerase chain reaction assay for specific detection of severe acute respiratory syndrome coronavirus 2
Zhang, Y., Dai, C., Wang, H., Gao, Y., Li, T., Fang, Y., Shen, Z., Chen, L., Chen, Z., Ma, X., Li, M.
10.1101/2020.08.27.20182832 — Posted: 2020-09-01
MAIT cell activation and dynamics associated with COVID-19 disease severity and outcome
Parrot, T., Gorin, J.-B., Ponzetta, A., Maleki, K. T., Kammann, T., Emgard, J., Perez Potti, A., Sekine, T., Rivera-Ballesteros, O., Karolinska COVID-19 Study Group, , Folkesson, E., Rooyackers, O., Eriksson, L. I., Norrby-Teglund, A., Ljunggren, H.-G., Bjorkstrom, N. K., Aleman, S., Buggert, M., Klingstrom, J., Stralin, K., Sandberg, J. K.
10.1101/2020.08.27.20182550 — Posted: 2020-09-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).